Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
Evolva Holding SA  publishes agenda for Annual General Meeting 2025
Evolva Holding SA publishes agenda for Annual General Meeting 2025
Evolva Holding SA publishes agenda for Annual General Meeting 2025
Sonova raises awareness for hearing health globally
Sonova raises awareness for hearing health globally
Sonova raises awareness for hearing health globally
EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
Evolva Holding SA publishes IFRS annual report 2024
Evolva Holding SA publishes IFRS annual report 2024
Evolva Holding SA publishes IFRS annual report 2024
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
Siegfried reports continued profitable growth fueled by strong underlying business
Siegfried reports continued profitable growth fueled by strong underlying business
Siegfried reports continued profitable growth fueled by strong underlying business
Evolva Holding SA: Shareholder Clearway requests general meeting
Evolva Holding SA: Shareholder Clearway requests general meeting
Evolva Holding SA: Shareholder Clearway requests general meeting
Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin
Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin
Lonza Delivers Solid 2024 Performance with CER Sales in Line with Prior Year and 29.0% CORE EBITDA Margin
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Sonova to present at the J.P. Morgan 2025 Healthcare Conference
Sonova announces changes to its Board of Directors
Sonova announces changes to its Board of Directors
Sonova announces changes to its Board of Directors
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Change in Evolva Holding SA's shareholder structure
Change in Evolva Holding SA's shareholder structure
Change in Evolva Holding SA's shareholder structure
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe